Publication | Open Access

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Atopic DermatitisAllergy MedicineOutcomes ResearchDutch Bioday RegistryDaily PracticeClinical DermatologyDermatologyMedicine52-Week Results